Li X - Search Results

1

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China.

Xu C, Si L, Wang W, Li Z, Song Z, Wang Q, Liu A, Yu J, Fang W, Zhong W, Wang Z, Zhang Y, Liu J, Zhang S, Cai X, Liu A, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Chen Y, Yuan J, Wang F, Jiang Z, Lin G, Pu X, Lin R, Liu W, Rao C, Lv D, Yu Z, Lei L, Li X, Tang C, Zhou C, Zhang J, Xue J, Guo H, Chu Q, Meng R, Wu J, Zhang R, Hu X, Zhou J, Zhu Z, Li Y, Qiu H, Xia F, Lu Y, Chen X, Ge R, Dai E, Han Y, Pan W, Luo J, Jia H, Dong X, Pang F, Wang K, Wang L, Zhu Y, Xie Y, Lin X, Cai J, Wei J, Lan F, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Huang J, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Wan B, Lv D, Wei Q, Kang J, Zhang J, Zhang C, Yu G, Ou J, Shi L, Li Z, Liu Z, Liu J, Yang N, Wu L, Wang H, Jin G, Yang L, Wang G, Fang M, Fang Y, Li Y, Wang X, Zhang Y, Ma S, Wang B, Zhang X, Song Y, Lu Y. Xu C, et al. Among authors: li y, li z, li w, li x. Thorac Cancer. 2022 Nov;13(21):3084-3097. doi: 10.1111/1759-7714.14644. Epub 2022 Sep 20. Thorac Cancer. 2022. PMID: 36127731 Free PMC article.

2

[Erlotinib in the treatment of advanced non-small-cell lung cancer (NSCLC)].

Tang CH, Liu XQ, Gao HJ, Li JJ, Guo WF, Li XY, Wang WX, Liu B, Qu LL, Wang WW. Tang CH, et al. Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):143-7. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20403247 Clinical Trial. Chinese.

3

Interleukin-4 -590T/C polymorphism influences the susceptibility to nonsmall cell lung cancer.

Li X, Shi W, Yu G, Lin L, Yang B, Li J, Guo W, Tang C, Wang H, Gao H, Qin H, Liu Y, Liu X. Li X, et al. Among authors: li j. DNA Cell Biol. 2012 May;31(5):797-800. doi: 10.1089/dna.2011.1425. Epub 2011 Dec 5. DNA Cell Biol. 2012. PMID: 22142023

4

A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients.

Liu Y, Liu B, Li XY, Li JJ, Qin HF, Tang CH, Guo WF, Hu HX, Li S, Chen CJ, Liu B, Gao HJ, Liu XQ. Liu Y, et al. J Exp Clin Cancer Res. 2011 Dec 6;30(1):111. doi: 10.1186/1756-9966-30-111. J Exp Clin Cancer Res. 2011. PMID: 22142557 Free PMC article.

5

[Clinic characteristics and prognosis in 102 non-small cell lung cancer patients less than 40 years old].

Qu L, Qin H, Liu X, Gao H, Li J, Wang W, Tang C, Guo W, Li X. Qu L, et al. Among authors: li j, li x. Zhongguo Fei Ai Za Zhi. 2013 Feb;16(2):73-7. doi: 10.3779/j.issn.1009-3419.2013.02.03. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23425898 Free PMC article. Chinese.

6

Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.

Li X, Kang X, Deng Q, Cai J, Wang Z. Li X, et al. Reprod Biol Endocrinol. 2013 Mar 1;11:16. doi: 10.1186/1477-7827-11-16. Reprod Biol Endocrinol. 2013. PMID: 23452939 Free PMC article.

7

[Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].

An J, Tang C, Wang N, Liu Y, Guo W, Li X, Wang Z, He K, Liu X. An J, et al. Among authors: li x. Zhongguo Fei Ai Za Zhi. 2013 May;16(5):233-9. doi: 10.3779/j.issn.1009-3419.2013.05.04. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23676979 Free PMC article. Chinese.

8

[How to make the choice in the retreatment of EGFR-TKI for advanced NSCLC patients who benefited from prior gefitinib therapy: the original drug or switching to a second EGFR-TKI?].

Tang C, Li X, Guo W, Li J, Qin H, Wang W, Qu L, An J, Gao H, Liu X. Tang C, et al. Among authors: li j, li x. Zhongguo Fei Ai Za Zhi. 2013 Jul;16(7):345-52. doi: 10.3779/j.issn.1009-3419.2013.07.03. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23866664 Free PMC article. Chinese.

9

Different treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancer.

Tang C, Gao H, Li X, Liu Y, Li J, Qin H, Wang W, Qu L, An J, Yang S, Liu X. Tang C, et al. Among authors: li j, li x. J Cancer Res Clin Oncol. 2014 Mar;140(3):427-33. doi: 10.1007/s00432-014-1582-x. Epub 2014 Jan 9. J Cancer Res Clin Oncol. 2014. PMID: 24401995

10

[Comparison of Efficacy and Safety of Different Therapeutic Regimens as  Second-line Treatment for Small Cell Lung Cancer].

Li Z, Liu X, Li J, Gao H, Tang C, Li X, Guo W, Qin H, Wang W, Qu L, Chen J. Li Z, et al. Among authors: li j, li x. Zhongguo Fei Ai Za Zhi. 2015 May;18(5):280-8. doi: 10.3779/j.issn.1009-3419.2015.05.05. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25975298 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,558 results

Search Page

Filters